We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+4.45%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$24.5B
AUM Growth
-$766M
Cap. Flow
+$1.16B
Cap. Flow %
4.71%
Top 10 Hldgs %
14.99%
Holding
4,039
New
907
Increased
1,143
Reduced
1,068
Closed
874

Sector Composition

Rank Sector Weight
1 Technology 10.7%
2 Consumer Discretionary 10.58%
3 Healthcare 6.83%
4 Industrials 5.75%
5 Financials 5.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTI icon
2876
TETRA Technologies
TTI
$1.23B
$156K ﹤0.01%
58,879
+24,635
+72% +$85.7K
HIVE
2877
HIVE Digital Technologies
HIVE
$792M
$155K ﹤0.01%
+47,251
New +$140K
AAN
2878
DELISTED
The Aaron's Company Inc
AAN
$155K ﹤0.01%
+16,090
New +$207K
EXFY icon
2879
Expensify
EXFY
$166M
$155K ﹤0.01%
+18,987
New +$169K
CFFN icon
2880
Capitol Federal Financial
CFFN
$1.08B
$154K ﹤0.01%
22,930
-9,869
-30% -$80.2K
RNAC icon
2881
Cartesian Therapeutics
RNAC
$232M
$154K ﹤0.01%
+3,698
New +$174K
HTGC icon
2882
Hercules Capital
HTGC
$2.94B
$154K ﹤0.01%
+11,961
New +$167K
BAER icon
2883
Bridger Aerospace
BAER
$107M
$154K ﹤0.01%
+33,791
New +$196K
TERN
2884
DELISTED
Terns Pharmaceuticals
TERN
$153K ﹤0.01%
+12,925
New +$124K
NUTX
2885
Nutex Health
NUTX
$1B
$153K ﹤0.01%
1,009
+847
+523% +$172K
ACTG icon
2886
Acacia Research
ACTG
$450M
$152K ﹤0.01%
+39,506
New +$167K
PYXS icon
2887
Pyxis Oncology
PYXS
$165M
$152K ﹤0.01%
+37,945
New +$75.8K
GRND icon
2888
Grindr
GRND
$2.64B
$152K ﹤0.01%
+24,461
New +$146K
VRCA icon
2889
Verrica Pharmaceuticals
VRCA
$86.2M
$152K ﹤0.01%
+2,340
New +$142K
WHWK
2890
Whitehawk Therapeutics
WHWK
$183M
$150K ﹤0.01%
+20,781
New +$222K
SLND icon
2891
Southland Holdings
SLND
$33.6M
$150K ﹤0.01%
+17,853
New +$164K
MPAA icon
2892
Motorcar Parts of America
MPAA
$261M
$150K ﹤0.01%
+20,117
New +$240K
XHR
2893
Xenia Hotels & Resorts
XHR
$1.98B
$149K ﹤0.01%
+11,390
New +$157K
STOK icon
2894
Stoke Therapeutics
STOK
$1.82B
$149K ﹤0.01%
+17,851
New +$161K
OXLC
2895
Oxford Lane Capital
OXLC
$830M
$148K ﹤0.01%
5,664
+1,713
+43% +$47.8K
MAGN
2896
Magnera Corp
MAGN
$488M
$147K ﹤0.01%
3,542
-13,754
-80% -$634K
GHM icon
2897
Graham Corp
GHM
$1.22B
$147K ﹤0.01%
+11,215
New +$136K
BLZE icon
2898
Backblaze
BLZE
$697M
$144K ﹤0.01%
+28,500
New +$173K
ARI
2899
Apollo Commercial Real Estate
ARI
$887M
$143K ﹤0.01%
+15,390
New +$170K
OLO
2900
DELISTED
Olo Inc
OLO
$142K ﹤0.01%
17,456
-122,933
-88% -$946K

Similar funds

Squarepoint's Q1 2023 Portfolio in Review

As of Q1 2023, Squarepoint held 4,039 positions worth $24.5B, down 3% from $25.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Squarepoint deployed $1.16B of net new capital in Q1 2023, opening 907 new positions and adding to 1,143 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,782,957 shares worth $210M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was State Street Materials Select Sector SPDR ETF, an estimated $233M trimmed.

  • Squarepoint's largest Q1 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,782,957 shares worth $210M.
  • Squarepoint added most to CVS Health in Q1 2023, an estimated $132M increase.
  • Squarepoint's biggest Q1 2023 reduction was State Street Materials Select Sector SPDR ETF, cutting an estimated $233M.
  • Squarepoint fully exited Mondelez International in Q1 2023, selling an estimated $95.9M.
  • Squarepoint's ten largest holdings make up 15% of its $24.5B portfolio in Q1 2023.
  • Squarepoint opened 907 new positions and closed 874 in Q1 2023.
  • Squarepoint's portfolio value fell 3% quarter-over-quarter to $24.5B.

Based on Squarepoint's 13F filing for Q1 2023, filed 15 May 2023.